I'm not so much talking about "me too" specifically, that said, I don't feel that minor tweaks to process or formula are deserving of another patent and many years of protections. And, as I said, I don't feel that there should be a single provider at all. The licensing for patents can be worked out, but imho if the sale of the drug required dual, independent sourcing as a requirement there would be at least some push downward on pricing.